PharmaCyte Biotech Inc (PMCB)

[The grateful smiths]

“Pharmacyte’s initial success with ifosfamide demonstrates that the concept of live-cell encapsulation is an effective method of targeting a drug to a specific site. But though the company is still investing heavily in developing the ifosfamide therapy, it has opted to pursue development of a cannabinoid-derived therapy at the same time as the ifosfamide therapy, on the grounds that cannabinoids have a wider application.
“Ifosfamide works best for pancreatic cancer,” Rabe says. “Cannabinoids, however, are effective against a broad range of cancers,” noting that they can be used for brain, breast, prostate, colon, lung, and skin cancers, in addition to pancreatic.


What initial success with Ifosfamide?!?!? How are these pumps legal? This was from 5 years ago people, but don’t worry, they stopped funding this program for now. Diabetes and all other cancers will have to wait while PMCB solves IPC first. Then they get the go ahead to solve EVERYTHING ELSE!

Remember they haven’t solved anything, just bought some other company’s unwanted tech. That’s it.

40 million could have paid for all three programs to continue at the same time, but then you would have had to work. Maybe do something for those salaries instead of move money around from one company to another. One consulting firm to another. One doctor to another. Read the financials people. Read em.